Importance of determination of protein C reactive (CRP), antigen carcino embryonnaire (ACE) and lacticodeshydrogenase (LDH) in cancer colorectal

Tunisie Medicale

Volumn 88, Issue 6, 2010, Pages 409-413

  Abaza, Hajer ^a   Ghanem, Abderraouf ^a   Jmal, Aouatef ^a   Boussen, Hamouda ^a   Harzallah, Latifa ^a   Rahal, Khaled ^a   Guemira, Fethi ^a  

^a NONE

Author keywords

Antigen carcino embryonnaire; C reactive protein; Colorectal cancer; Lactic deshydrogenase; Survival

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; LACTATE DEHYDROGENASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; PROTEIN DETERMINATION; SURVIVAL; BLOOD; COLORECTAL TUMOR; FEMALE; MALE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 77954703403     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Benhamiche AM. Cancer du colon: Epidémiologie descriptive et groupes à risque élevé. Gastroentérol Clin Biol 2004; 28:21-32.
2. Bedioui H. La prise en charge des adénocarcinomes du colon. Apropos de 55 cas. Thèse de Médecine Tunis 2001.
3. Bel Hadj Hmida Y, Tahri N, Sellami A, Yangui N, Jlidi R, Beyrouti MI et all. Sensibilité, spécificité et valeur pronostique de l'ACE dans le cancer colorectal: résultats des séries tunisiennes et revue de la littérature. Tunis Med 2001; 79:434-40.
4. Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994; 60: 528-32.
5. Hamdani I. Les cancers colorectaux. Profil epidemiologique et évolutif. A propos de 150 cas. Thèse Médicine Tunis 2004.
6. Fernandes L, Kim SB, Matos D. Cytokeratines and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal cancer. World J Gastroenterolol 2005; 11:645-8. (Pubitemid 40227373)
7. Schwartz M K. Lactic dehydrogenase. An old enzyme reborn or a cancer marker. Am J clin Path 1991; 96:441-3.
8. Bonthius D, Landheer M, Bilgen E, Slootmans F, Lier H. Small but significant survival benefit in patients who undergo routine follow-up after colorectal cancer surgery. European Journal of Surgical oncology 2004; 30:1093-7. (Pubitemid 40267814)
9. McCall JL, Black R, Rich C, Harvey J, Baker R, Watts J. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994; 37:875.
10. Cerdan F, Diez M, Gomez JJ, Balibrea JL. The prognostic value of common predictive variables in rectal cancer. Rev Esp Enferm Dig 1995; 87:205-10.
11. Forones N, Tanaka M. CEA and CA19-9 as prognostic indexes in colorectal cancer. Hepatogastroenterology 1999; 46:905.
12. Reiter W, Stieber P, Reuter C, Nagel D, Lau-werner U. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res 2000; 20:5195-8. (Pubitemid 32319106)
13. Chen CC, Yang Sh, Lin JK, Lin TC, Chen W Jiang JK et all. Is it reasonable to add preoperative serum level of CEA and CA 19-9 to staging for colorectal cancer? J Surg Res 2005; 124:169-74.
14. Casamassima A, Picciariello M, Quarranta M, Berardino R, Ranierie C et coll. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherpy. J Urol 2005;173:52-5. (Pubitemid 39627670)
15. Kami J, Kowalska M, Noacki M, Chwali M, Rysi A, Fuksiewicz M.CRP, TNF·, IL-1, IL6, IL8 and IL10 in blood serum of colorectal cancer patients. Path Oncol Res 2000;6:38-41.
16. Hatada T, Miki C. Nutritional status and postoperative cytokine response in colorectal cancer patients. Cytokine 2000; 12:1331-6.
17. Erlinger T, Platz E, Rifai N, Helzlsouer K. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004; 291:585-90.
18. Nozoe T, Matsumata T, Kitamura M. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognostic in colorectal cancer. Am J Surg 1998;176:335-8.
19. Nielson H, Christensen I, Sorensen S. Preoperative plasminogen activator inhibitor type-1 and serum C-recative protein levels in patients with colorectal cancer. Ann Surg Oncol 2000; 7:617-23.
20. Elahi MM, Mc Milan D, Mc Ardle C, Angerson W, Sattar N. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer 2004; 48:171-3. (Pubitemid 39045778)
21. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M. The impact of preoperative serum C-reactive protein on the prognostic of patients with hepatocellular carcinoma. Cancer 2005; 103:1856-64. (Pubitemid 40563258)
22. Mahmoud FA, Rivera NI. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 2002; 4:250-5.
23. Miki C, Konishi N, Ojima E, Hatada T, Inoue Y, Kusunoki M. Creactive protein as a prognostic variable that reflets uncontrolled upregulation of the IL-1, Il-6 network system in colorectal carcinoma. Dig Dis Sci 2004; 49:970-6.
24. Nikiteas N, Tzanakis N, Gazouli M. Serum IL6, TNF· and CRP levels in greek colorectal cancer patients: prognostic implications. World J Gastroenterol 2005,21:1639-43. (Pubitemid 40520804)
25. Henk J, Gerard TB, Rusol PH. The clinical value of lactate dehydrogenase in serum: a quantitative review. Eur J clin Chem clin Biochem 1997; 35:569-79.
26. Mate J, Duran R, Lara S, Pajares JM, Moreno R. A study of the lactic dehydrogenase isoenzyme patterns in the adenoma-carcinoma sequence of the colon. Hepatogastroenterology 1993; 40:471-4. (Pubitemid 23310268)
27. GriffiniP, Freitas I, Vigorelli E, Van Noorden CJ. Changes in the zonation of of lactate dehydrogenase activity in lobules of rate liver after experimentally induced colon carcinoma metastases. Anticancer Res 1994; 14:2537-40.
28. Lin JT, Wang WS, Yen CC, Liu JH, Yang MH. Outcome of colorectal carcinoma in patients under 40 years of age. J Gastroenterol Hepatol 2005; 20:900-5.